recombinant nonavalent human papillomavirus vaccine (Yidao Biotechnology/Jiangsu Zhonghui Yuantong Biotechnology)

N/A

Report date: 2025/03/20 09:39:02

Base Information

Drug Namerecombinant nonavalent human papillomavirus vaccine (Yidao Biotechnology/Jiangsu Zhonghui Yuantong Biotechnology)
Drug Alias Nameprotein subunit vaccine (Yidao Biotechnology/Jiangsu Zhonghui Yuantong Biotechnology)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsVulvar Intraepithelial NeoplasiaHyperplasiaVaginal Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Yidao Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Yidao Biotechnology Co LtdAb&B Bio-tech Co Ltd JS
Inactive CompaniesN/A
Active IndicationsVulvar Intraepithelial NeoplasiaHyperplasiaVaginal Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A